PTM Therapeutics
Founded in the San Francisco Bay Area, PTM Therapeutics was started based on the belief that Post Translational Modifications (PTMs) create more disease specific targets for therapeutic antibodies. PTM Therapeutics is striving to discover new targets and develop new therapeutics for the treatment of chronic diseases and cancer.
Using PTM Therapeutic’s antibody discovery platform, PTM Therapeutics currently has two promising programs
PTM-001 for the treatment of Inflammatory Bowel Disease/Ulcerative Colitis
PTM-001-ADC for the treatment of Metastatic Colon Cancer/Colon Cancer
PTM is a company that develops therapeutics for the betterment of human healthspan and well-being. As a company in the healthcare industry, we feel strongly and state unequivocally:
Our company understands that policies restricting any person’s access to comprehensive health care, including abortion, threatens the health, independence, and economic stability of our workers and customers.
Simply put, we stand against policies that restrict care based on a person’s identity. It impairs our ability to build a workforce, recruit top talent across states, and protect the well-being of all the people who keep our businesses thriving day in and out.